EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Increased Healthcare Utilization and Differential Outcomes for Pediatric Cancer Versus Non‐Cancer Patients

Erhöhte Inanspruchnahme des Gesundheitswesens und unterschiedliche Outcomes bei pädiatrischen Krebspatient:innen versus Nicht-Krebs-Patient:innen

Yujie Chen, Martin Yi, Catherine C Aftandilian, Melissa P Beauchemin iD, Christine Cunningham iD, Emily Larimer, Jennifer Oberg iD, Benjamin L May, Keith Morse, Karthik Natarajan iD, David Noyd iD, Vicki Soucek iD und 4 weitere

Cancer Medicine · 2026-11 · 15 (11)

DOI: 10.1002/cam4.72459 ↗

Auf einen Blick

Bei 2.810 Krebspatient:innen und 11.240 Nicht-Krebs-Patient:innen war die Inanspruchnahme des Gesundheitswesens in der Krebsgruppe höher. Auch die 6-Monats-Mortalität war höher.

Fragestellung

Beschreibt die Studie die Inanspruchnahme des Gesundheitswesens und 6-Monats-Outcomes bei pädiatrischen Krebs- versus Nicht-Krebs-Patient:innen?

Methode

Multizentrische retrospektive Studie mit OMOP CDM; pädiatrische Patient:innen 0–18 Jahre bei erster Medikamentengabe; Outcomes innerhalb von 6 Monaten.

Ergebnisse

Alle untersuchten Inanspruchnahme-Maße waren bei Krebspatient:innen häufiger. Größte Unterschiede: langer stationärer Aufenthalt RR 26,32 (95 %-KI 15,00–46,17), CT RR 23,59 (95 %-KI 19,24–28,92), Blutkultur RR 37,04 (95 %-KI 9,58–143,14), i.v. Medikation RR 17,69 (95 %-KI 8,75–35,75).

Schlussfolgerung der Autor:innen

Mit dem OMOP CDM fanden die Autor:innen eine höhere Inanspruchnahme des Gesundheitswesens und schlechtere klinische Outcomes bei pädiatrischen Krebspatient:innen als bei Nicht-Krebs-Patient:innen.

Kernaussagen

  • Krebs: höhere Inanspruchnahme in allen untersuchten Bereichen
  • Langer stationärer Aufenthalt, CT, Blutkultur und i.v. Medikation am stärksten erhöht
  • 6-Monats-Mortalität bei Krebs höher: RR 38,37 (95 %-KI 12,91–114,04)

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Medicine, online erschienen am 29.10.2026. Verfasst von Yujie Chen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Neoplasms, Patient Acceptance of Health Care. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Observational Medical Outcomes Partnership Common Data Model (OMOP CDM) is a data standard that enables multicenter research. Primary objective was to describe the magnitude of healthcare utilization in pediatric cancer versus non‐cancer patients. Secondary objective was to compare 6‐month clinical outcomes related to abnormal lab tests and mortality.

Methods

In this multicenter retrospective study, we included pediatric patients 0–18 years at first medication administration. Cancer patients had a malignant neoplastic disease diagnosis and received chemotherapy. Index date was the first chemotherapy date. Non‐cancer patients were assigned analogous index dates based on randomly sampled first medication to chemotherapy intervals. Outcomes were measured within 6 months of index date. Healthcare utilization included encounters, procedures, radiology, lab tests, and medications.

Results

Among 2810 cancer and 11,240 non‐cancer patients, all evaluated healthcare utilization measures were significantly more common in cancer patients. The largest relative differences were observed for long inpatient stay (risk ratio [RR] 26.32, 95% confidence interval [CI] 15.00–46.17), computed tomography (RR 23.59, 95% CI 19.24–28.92), blood culture (RR 37.04, 95% CI 9.58–143.14), and intravenous medication (RR 17.69, 95% CI 8.75–35.75). Death within 6 months was higher for cancer versus non‐cancer patients (RR 38.37, 95% CI 12.91–114.04).

Conclusions

Using the OMOP CDM, we found greater healthcare utilization and worse clinical outcomes among pediatric cancer patients than non‐cancer patients, with the largest relative differences observed for inpatient stay, computed tomography, blood culture, and intravenous medication. These findings provide insight into resource utilization patterns and illustrate the OMOP CDM research potential for multicenter studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsPatient Acceptance of Health CareAdolescentChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleRetrospective Studies

Stichwörter der Autor:innen

OMOP common data modelhealthcare utilizationoncologypediatric

Autor:innen und Institutionen

  • Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California, USA.
  • Columbia University School of Nursing/Herbert Irving Cancer Center, New York, New York, USA.
  • Ben Towne Center for Childhood Cancer and Blood Disorders Research and the Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
  • Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA.
  • Stanford Center for Biomedical Informatics Research, Stanford University, Palo Alto, California, USA.

ORCID-Profile: Melissa P Beauchemin, Christine Cunningham, Jennifer Oberg, Karthik Natarajan, David Noyd, Vicki Soucek, Rhea K Khurana, Lillian Sung

Zitieren

APA

Chen, Y., Yi, M., Aftandilian, C. C., Beauchemin, M. P., Cunningham, C., Larimer, E., Oberg, J., May, B. L., Morse, K., Natarajan, K., Noyd, D., Soucek, V., Khurana, R. K., Sim, P., Guo, L. L., & Sung, L. (2026). Increased Healthcare Utilization and Differential Outcomes for Pediatric Cancer Versus Non‐Cancer Patients. Cancer Medicine, 15(11). https://doi.org/10.1002/cam4.72459

Vancouver

Chen Y, Yi M, Aftandilian CC, Beauchemin MP, Cunningham C, Larimer E, et al. Increased Healthcare Utilization and Differential Outcomes for Pediatric Cancer Versus Non‐Cancer Patients. Cancer Medicine. 2026;15(11). doi:10.1002/cam4.72459

BibTeX
@article{Chen2026,
  author = {Chen, Yujie and Yi, Martin and Aftandilian, Catherine C and Beauchemin, Melissa P and Cunningham, Christine and Larimer, Emily and Oberg, Jennifer and May, Benjamin L and Morse, Keith and Natarajan, Karthik and Noyd, David and Soucek, Vicki and Khurana, Rhea K and Sim, Phil and Guo, Lin Lawrence and Sung, Lillian},
  title = {Increased Healthcare Utilization and Differential Outcomes for Pediatric Cancer Versus Non‐Cancer Patients},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  doi = {10.1002/cam4.72459}
}
Kostenlos starten →